Jill Hagenkord MD, FCAP

Dr. Jill Hagenkord, MD, FCAP is the Chief Medical Officer of Optum Genomics. Jill is a board-certified pathologist with subspecialty boards in molecular genetic pathology and an additional fellowship in pathology/oncology informatics. Jill’s expertise is in health product strategy, coding/coverage/reimbursement of molecular diagnostics, medical and regulatory affairs, health policy, clinical laboratory medicine, molecular diagnostics, population health, provider education, patient engagement, and medical diligence.

Dr. Hagenkord serves on a number of medical professional societies as an active member in the Association for Molecular Pathology, the College of American Pathologists, The American College of Medical Genetics and Genomics, and the National Academies of Science, Engineering, and Medicine’s Roundtable on Genomics and Precision Health. Jill received her MD from Stanford University School of Medicine in 1999, did residency training at the University of California at San Francisco and the University of Iowa, and completed fellowships at the University of Pittsburgh Medical Center. Subsequently, Dr. Hagenkord practiced pathology at Creighton University Medical Center where she founded iKaryos Diagnostics. Jill was previously the Chief Medical Officer at Color Genomics, 23andMe, Invitae, and Complete Genomics. More details on Jill’s experience can be found here